ESOT Virtual

Direct Access Request
This content is available to all registered users. Click on the registration button.
Congress delegate:  Please request a direct access link here
Non-delegate:  It is also possible to purchase on-demand access, click here to create an account.
REDUCTION OF RENAL GRAFT FIBROSIS WITH VALGANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS COMPARED TO PREEMPTIVE THERAPY: A RANDOMIZED CONTROLLED TRIAL
Prof. Tomas Reischig
Prof. Tomas Reischig
Affiliations:
Dept. of Internal Medicine I, Nephrology Division, Faculty of Medicine in Pilsen, Charles University, and Teaching Hospital, Pilsen, Czech Republic
ESOT Virtual. Reischig T. 09/18/2023; 402920;
user
Prof. Tomas Reischig
Affiliations:
Dept. of Internal Medicine I, Nephrology Division, Faculty of Medicine in Pilsen, Charles University, and Teaching Hospital, Pilsen, Czech Republic

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies